Prior myocardial infarction, coronary artery disease extent, diabetes mellitus, and CERT2 score for risk stratification in stable coronary artery disease

Hilvo et al. European Journal of Preventive Cardiology. Published 28 August 2021

Lue lisää  

Comparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients

Leiherer et al. European Journal of Preventive Cardiology. Published: 21 August 2021

Lue lisää  

Absolute and relative risk prediction in cardiovascular primary prevention with a modified SCORE chart incorporating ceramide-phospholipid risk score and diabetes mellitus

Hilvo et al. European Heart Journal Open, Published: 13 July 2021

Lue lisää  

Primary cardiovascular risk prediction by LDL-cholesterol in Caucasian middle-aged and older adults: a joint analysis of three cohorts

Hilvo et al. European Journal of Preventive Cardiology, Published 01 June 2021

Lue lisää  

A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer

Salminen et al. Cancers 2021, 13(8), 1764.

Lue lisää  

Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome

Gencer et al. 2020 European Journal of Preventive Cardiology. Published online Dec 2020

Lue lisää  

Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors

Meeusen et al. 2020 Clinica Chimica Acta 511 (2020) 138–142

Lue lisää  

Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification

Hilvo et al. 2020. Frontiers in Endocrinology. September 2020 | Volume 11 | Article 570628

Lue lisää  

Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography

Mantovani et al. 2020 Diabetes & Metabolism, 46(2):150-157.

Lue lisää  

Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

Hilvo et al. 2020 JAHA, Published Online May 2020

Lue lisää  

Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients

Hilvo et al. 2019 Eur Heart J. Published online: 18 June 2019

Lue lisää  

Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths

Ruuth M. et al. 2018 European Heart Journal, 2018: 39 (27),2562–2573.

Lue lisää  

Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients

Anroedh et al. 2018 The Journal of Lipid Research. June 1, 2018, doi: 10.1194/jlr.P081281

Lue lisää  

Ceramide stearic to palmitic acid ratio predicts incident diabetes

Hilvo et al. Diabetologia (2018) 61: 1424. https://doi.org/10.1007/s00125-018-4590-6

Lue lisää  

Keramidit ja sepelvaltimotauti

Laaksonen et al. 2018 Duodecim 2018;134:456–64

Lue lisää  

PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions

Hilvo et al. 2018 Atherosclerosis Volume 269, Pages 159–165

Lue lisää  

High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism

Braicu et al. Oncotarget. 2017; 8:102912-102922

Lue lisää  

Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort

Havulinna et al. Arterioscler Thromb Vasc Biol. 2016; 36

Lue lisää  

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol

Laaksonen et al. European Heart Journal, Published online: 28 April 2016

Lue lisää  

Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas

Hilvo et al. Cancer Res. 2016 Feb 15;76(4):796-804

Lue lisää